-
Study aim
-
Determining the effect of local insulin administration on wound healing in diabetic patients who underwent surgery
-
Design
-
Clinical trial, with parallel groups, double-blind, randomized, phase 3 on 40 patients
-
Settings and conduct
-
The current study is a randomized clinical trial that will be conducted on patients referred to Al-Zahra and Shahid Beheshti hospitals to perform laparotomy with Feinstein's standard incision. Controls will be distributed to the patient in sealed envelopes that are coded.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
1. having diabetes,
2. Indication of laparotomy with standard Feinstein incision.
3. Receiving standard prophylactic antibiotics,
4. Declaration of informed consent to participate in the study.
Criteria for not entering the study:
1. Have an underlying disease that affects the wound healing process, such as cancer and neoplasm, immunodeficiency, history of chemotherapy and radiotherapy,
2. Re-incision in similar site of previous surgery
3. Visceral injury during surgery
4. Simultaneity of another surgery,
5. The need for blood transfusion during surgery
-
Intervention groups
-
Patients in the intervention group underwent subcutaneous wound injection with regular insulin at the rate of 0.2 units per kilogram of body weight diluted with 5 cc of distilled water and then using a 5 cc syringe and insulin needle subcutaneously and uniformly for 10 Feinstein cut centimeter is injected. This injection will be done once a day on the 1st, 2nd, 3rd, 5th and 7th days after the operation.
-
Main outcome variables
-
Infection and purulent discharge, pain, necrotizing fasciitis, granulation tissue formation, wound healing time, cellulitis, bleeding, wound surface